Clinical trials for Chronic inflammatory demyelinating polyneuropathy
31 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT07540221A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating PolyradiculoneuropathyGrifols Therapeutics LLC
- RECRUITINGPhase 3NCT06752356A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Kedrion S.p.A. · PI: Miranda Norton, PhD
- RECRUITINGNCT07273903Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart DevicesHeinrich-Heine University, Duesseldorf · PI: Marc G Pawlitzki, PD Dr. med.
- RECRUITINGPhase 3NCT07091630A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDPargenx
- ENROLLING BY INVITATIONPhase 2NCT07188844An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Immunovant Sciences GmbH
- RECRUITINGNCT07154524Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)University of Ulm · PI: Johannes Dorst
- RECRUITINGPhase 3NCT06920004A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDPargenx
- RECRUITINGNCT07264426Real-World Efgartigimod Effectiveness in CIDP: A Prospective Studyargenx
- RECRUITINGPhase 2NCT06798012A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Takeda · PI: Study Director
- RECRUITINGPhase 3NCT06747351A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Takeda · PI: Study Director
- RECRUITINGNCT06538064A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical CareTakeda · PI: Study Director
- ACTIVE NOT RECRUITINGPhase 2NCT07027111Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDPNuvig Therapeutics, Inc.
- RECRUITINGNCT06968975Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)Sanofi
- ENROLLING BY INVITATIONPhase 3NCT06859099Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDPSanofi
- RECRUITINGPhase 2NCT07032662IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Immunovant Sciences GmbH
- RECRUITINGPhase 3NCT06858579A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)Dianthus Therapeutics
- RECRUITINGPhase 3NCT06714838Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating PolyneuropathyAmsterdam University Medical Center (UMC), Location Academic Medical Center (AMC)
- RECRUITINGPhase 3NCT06290141A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Sanofi
- RECRUITINGPhase 3NCT06290128A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkSanofi
- RECRUITINGPhase 3NCT04929236Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) PatientsOctapharma
- RECRUITINGNCT06040567Polyneuropathy, Impairments and Physical Activity - The PolyImPAct StudyRigshospitalet, Denmark · PI: Britt S Pedersen
- RECRUITINGNCT06183645Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.Centre Hospitalier Universitaire de Liege · PI: Margaux Poleur, Dr
- RECRUITINGPhase 2NCT04881682Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)University of Ulm · PI: Johannes Dorst, Prof
- ACTIVE NOT RECRUITINGPhase 2NCT05581199To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDPImmunovant Sciences GmbH
- RECRUITINGPHASE2, PHASE3NCT05327114Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Janssen Research & Development, LLC · PI: Janssen Research & Development, LLC Clinical Trial
- RECRUITINGPhase 1NCT05584631IVIG vs SCIG in CIDPRutgers, The State University of New Jersey · PI: Luigi Brunetti, PhD
- RECRUITINGNCT04672733Hizentra® in Inflammatory Neuropathies - pHeNIx StudyCSL Behring · PI: Study Director
- ACTIVE NOT RECRUITINGPhase 3NCT05084053A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)Takeda · PI: Study Director
- ACTIVE NOT RECRUITINGPhase 2NCT04280718A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)argenx
- RECRUITINGPhase 4NCT04589299Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)University of Aarhus · PI: Henning Andersen, MD,DMSc,PhD
- RECRUITINGPhase 4NCT03684018Two Dose Levels of Privigen in Pediatric CIDPCSL Behring · PI: Study Director